Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
BMC Cancer|August 5, 2024
Laparoscopic versus open surgery for rectal neuroendocrine tumors: a multicenter real-world studyXinyu Zeng, Chengguo Li, Minhao Yu, et al.
Asia Pacific Journal of Clinical Nutrition|June 4, 2026
Dietary inflammatory index and unfavorable dietary patterns associated with ischemic stroke in ChinaJianchun Yu, Wei Chen, Gang Xiao, et al.
Diseases of the Colon and Rectum|March 7, 2024
Local Excision Versus Radical Resection for Grade 2 Rectal Neuroendocrine Tumors: A Multicenter Propensity Score-Matched AnalysisXinyu Zeng, Rui Zhang, Weizhong Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2020
Serial Circulating Tumor DNA in Predicting and Monitoring the Effect of Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer: A Prospective Multicenter StudyJiaolin Zhou, Changxi Wang, Guole Lin, et al.
Frontiers in Immunology|June 24, 2025
Insights into immune-related adverse events in colorectal cancer patients receiving neoadjuvant immunotherapy: findings from a multicenter registry studyChentong Wang, Quan Wang, Jiaolin Zhou, et al.
Molecular Cancer Therapeutics|April 25, 2019
Genotyping of Circulating Tumor DNA Reveals the Clinically Actionable Mutation Landscape of Advanced Colorectal CancerWeiguo Cao, Yaping Xu, Lianpeng Chang, et al.
Nature Medicine|January 6, 2025
Neoadjuvant chemoradiation with or without PD-1 blockade in locally advanced rectal cancer: a randomized phase 2 trialYingchi Yang, Kai Pang, Guole Lin, et al.
BMC Cancer|September 17, 2023
Interaction analysis of high-risk pathological features on adjuvant chemotherapy survival benefit in stage II colon cancer patients: a multi-center, retrospective studyKexuan Li, Fuqiang Zhao, Yuchen Guo, et al.
Gut|February 26, 2026
Consensus guidance of immune checkpoint inhibitors in locally advanced rectal cancerZhengyang Yang, Fan Xia, Jian Li, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2025
Feasibility of ctDNA-guided precision neoadjuvant therapy in locally advanced rectal cancer: Insights from the ongoing CINTS-R trialXiao Zhang, Jiaolin Zhou, Jianhao Geng, et al.
Pageof 10